NCCN Foundation Provides Grants to Enhance Lung Cancer Screening Quality and Access
The National Comprehensive Cancer Network (NCCN) has recently announced its latest initiative to improve lung cancer screening rates through the awarding of grants to four promising research projects as part of its Oncology Research Program (ORP). With lung cancer taking the lead as the number one cause of cancer mortality across genders, the urgency to enhance screening practices has never been greater. In the United States alone, more than 225,000 new cases of lung cancer were projected for the year 2025. Despite these alarming statistics, current screening rates remain disappointingly low when compared to other types of cancer screenings.
The NCCN's ORP aims to identify and support innovative research that can significantly elevate the standards of care in cancer treatment and prevention. Funding for these vital projects is being provided through a partnership with Merck, a global leader in biopharmaceutical innovations. The selected projects focus on enhancing the adoption of guideline-concordant screening recommendations while simultaneously tackling issues of equity and access.
Among the recipients is Elizabeth Bouchard, PhD, from Roswell Park Comprehensive Cancer Center, who will be implementing "The I CAN Intervention." This innovative approach utilizes social networks to boost participation in lung cancer screenings, targeting disparities that often prevent vulnerable populations from receiving necessary care. By fostering connections within communities, the project aims to inform and motivate eligible individuals to pursue timely screening.
Similarly, Debra L. Friedman, MD, MS, from Vanderbilt-Ingram Cancer Center, will lead a project titled "Imaging for Timely Screening (LIFT)." This initiative seeks to streamline the process of lung cancer screening by improving imaging techniques and protocols, ensuring that screenings are both timely and efficient.
Katharine A. Rendle, PhD, MSW, MPH, from the Abramson Cancer Center at the University of Pennsylvania, will conduct the "Bridging Communities and Clinics to Improve Lung Cancer Screening" project. This endeavor focuses on building strong partnerships between healthcare providers and community organizations, which is crucial for increasing awareness and accessibility of lung cancer screening services.
Additionally, Ilana Richman, MD, and Lynn Tanoue, MD, from Yale Cancer Center will implement a project centered around a "Multilevel Intervention to Support Retention in Annual Lung Cancer Screening." This project aims not only to initiate screenings but also to keep patients engaged in their annual screening schedules, fostering long-term adherence.
These selected research initiatives underwent rigorous peer reviews conducted by a Scientific Review Committee comprising leading experts in diverse specialties from NCCN Member Institutions. The goal is not just to implement successful projects but to create sustainable and impactful change over the two-year course of the funding.
The NCCN ORP continues to support the advancement of innovative methodologies in cancer research, ensuring that the latest discoveries translate into practical applications in clinical settings. By maintaining a shared resource website and providing access to best practices, the NCCN encourages collaboration in lung cancer research, helping to foster an environment where knowledge and resources can be exchanged freely among institutions.
As part of its broader mission, the NCCN, a not-for-profit alliance of renowned cancer centers, is committed to advancing quality, effective, and equitable care. The NCCN® Clinical Practice Guidelines, a cornerstone of this effort, provide evidence-based recommendations that empower both healthcare professionals and patients in their decision-making processes related to cancer treatment and prevention.
In conclusion, this funding initiative marks a significant step in the fight against lung cancer, with the potential to save lives and improve overall health outcomes in affected populations. The NCCN team expresses its hopes that these projects will lead to tangible improvements in lung cancer screening rates, ultimately enhancing quality of life for countless individuals at risk.
For more information about the NCCN's Oncology Research Program and its ongoing initiatives, please visit NCCN.org/orp.